Literature DB >> 22079794

Discontinuation of unnecessary medications in older adults.

Nicole J Brandt1, Richard G Stefanacci.   

Abstract

OBJECTIVE: Identifying and managing the use of medications that may be discontinued is a daunting task for the health care team, especially for the consultant pharmacist. This article discusses a framework to evaluate the risks and benefits of medications. A case-based approach will be employed to demonstrate the application of evidence-based medicine and the challenges that pharmacists face in attempting to discontinue medications in older adults. DATA SOURCES: Medline and Micromedex were used as resources for primary literature as well as drug information. STUDY SELECTION: Studies were identified based on their relevance to the case to demonstrate the importance of applying emerging literature and evidence-based medicine. DATA EXTRACTION: Guidelines on managing osteoporosis as well as diabetes in older adults were used for this case. DATA SYNTHESIS: A structured framework was applied to demonstrate considerations when tackling challenging medication regimens.
CONCLUSION: Patient-centered, individualized medication regimens need to be developed and updated based on the needs of the patient as well as the wishes of the family and caregivers. This is a dynamic process that benefits from the consultant pharmacist, who understands the complexity of the medications and is essential to addressing the use of unnecessary medications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079794     DOI: 10.4140/TCP.n.2011.845

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  2 in total

Review 1.  Decision making about change of medication for comorbid disease at the end of life: an integrative review.

Authors:  Ronald T C M van Nordennen; Jan C M Lavrijsen; Kris C P Vissers; Raymond T C M Koopmans
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

2.  Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.

Authors:  Emily Reeve; Sepehr Shakib; Ivanka Hendrix; Michael S Roberts; Michael D Wiese
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.